|
DECEMBER'S BEST FEATURED EDITORIAL |
|
|
|
Why Feasibility Still Feels Broken | By Dan Schell, Chief Editor, Clinical Leader | During an interview with Dresden Whitehead of Avacare Clinical Research Network, her take on feasibility mirrored concerns raised during a 2024 Clinical Leader Live (CLL) webinar. She highlighted repetitive questionnaires, unclear sponsor expectations, and the challenges new investigators face. |
|
|
|
DECEMBER'S BEST INDUSTRY INSIGHTS |
|
|
|
Waiver Of Consent Vs Waiver Of Written Consent | By Niecy Duncan, Castor | Explore the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials. |
|
|
Future Predictions For Clinical Technologies | By Kees Van Ooik, Almac Clinical Technologies | In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems. |
|
|
DECEMBER'S BEST SOLUTIONS |
|
|
|
|
|
| Connect With Clinical Leader: |
|
|
|
|